NCT04249154View on ClinicalTrials.gov

Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

December 15, 2026

Study Completion Date

December 15, 2027

Conditions
Prostate Cancer
Interventions
DRUG

Eligard

Eligard dose of 22.5mg given, 50Gy in 20 treatments of radiation therapy to start 12 weeks after first injection concurrent with second injection of Eligard

Trial Locations (2)

H4A 3J1

RECRUITING

McGill University Health Centre- Cedars Cancer Centre, Montreal

RECRUITING

McGill University Health Centre-Cedars Cancer Centre, Montreal

All Listed Sponsors
collaborator

Tolmar Inc.

INDUSTRY

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER